Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 5:58 pm Unchanged |
2024-11-12 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 162,973 4.800% |
0 (Unchanged) |
Filing History |
| 2024-08-12 8:59 pm Unchanged |
2024-08-08 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 162,973 8.400% |
0 (Unchanged) |
Filing History |
| 2024-05-13 4:54 pm Unchanged |
2024-03-19 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 162,973 9.500% |
0 (Unchanged) |
Filing History |
| 2024-02-14 6:49 pm Sale |
2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
EcoR1 Capital, LLC | 0 0.000% |
-80,985 (Position Closed) |
Filing History |
| 2024-02-14 2:12 pm Sale |
2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 0 0.000% |
-63,358 (Position Closed) |
Filing History |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Tempest Therapeutics, Inc. TPST |
FMR LLC | 33,226 2.244% |
-16,613 (-33.33%) |
Filing History |
| 2024-02-08 5:41 pm Unchanged |
2023-11-08 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 162,973 11.000% |
0 (Unchanged) |
Filing History |
| 2023-11-09 5:28 pm Unchanged |
2023-08-10 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 162,973 15.900% |
0 (Unchanged) |
Filing History |
| 2023-02-14 2:57 pm Unchanged |
2022-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 63,358 7.830% |
0 (Unchanged) |
Filing History |
| 2023-02-14 12:10 pm Purchase |
2022-04-29 | 13G | Tempest Therapeutics, Inc. TPST |
EcoR1 Capital, LLC | 80,985 9.990% |
80,985 (New Position) |
Filing History |
| 2022-05-09 5:26 pm Purchase |
2022-04-29 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 162,973 20.500% |
72,321 (+79.78%) |
Filing History |
| 2022-02-17 4:19 pm Purchase |
2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
LAV Regulus Ltd | 11,826 2.200% |
11,826 (New Position) |
Filing History |
| 2022-02-14 4:31 pm Sale |
2021-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
Ikarian Capital, LLC | 58,803 0.900% |
-31,065 (-34.57%) |
Filing History |
| 2022-02-14 06:20 am Purchase |
2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Roche Finance Ltd | 5,586 1.100% |
5,586 (New Position) |
Filing History |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Citadel Advisors LLC | 28 0.000% |
28 (New Position) |
Filing History |
| 2022-02-10 7:41 pm Purchase |
2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 90,652 17.100% |
90,652 (New Position) |
Filing History |
| 2022-01-03 4:15 pm Purchase |
2021-12-22 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 63,358 11.480% |
39,499 (+165.56%) |
Filing History |
| 2021-07-15 4:31 pm Sale |
2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 23,859 4.670% |
-25,538 (-51.70%) |
Filing History |
| 2021-07-08 4:25 pm Purchase |
2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 49,397 9.680% |
49,397 (New Position) |
Filing History |
| 2021-07-06 10:59 am Purchase |
2021-07-02 | 13G | Tempest Therapeutics, Inc. TPST |
FMR LLC | 49,838 9.764% |
49,838 (New Position) |
Filing History |